Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib - Concepedia

Concepedia

Publication | Closed Access

Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib

42

Citations

25

References

2013

Year

Maria Serova, Armand de Gramont, Annemilaï Tijeras‐Raballand, Célia Dos Santos, María E. Riveiro, Khémaies Slimane, Sandrine Faivre, Éric Raymond

Cancer Chemotherapy and Pharmacology

UrologyOncologyMedicineAnti-cancer AgentCancer TreatmentPharmacologyTumor MicroenvironmentDual Pi3k/mtor Inhibitors

References

	Year	Citations

Page 1